Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis: A Profile of Its Use.
Journal
Clinical drug investigation
ISSN: 1179-1918
Titre abrégé: Clin Drug Investig
Pays: New Zealand
ID NLM: 9504817
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
pubmed:
2
10
2019
medline:
28
1
2020
entrez:
2
10
2019
Statut:
ppublish
Résumé
Glycopyrronium tosylate (Qbrexza
Identifiants
pubmed: 31571127
doi: 10.1007/s40261-019-00853-x
pii: 10.1007/s40261-019-00853-x
pmc: PMC6877702
doi:
Substances chimiques
glycopyrronium tosylate
1PVF6JLU7B
Glycopyrrolate
V92SO9WP2I
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1141-1147Commentaires et corrections
Type : ErratumIn
Références
J Am Acad Dermatol. 2011 Apr;64(4):690-5
pubmed: 21334095
Pediatr Dermatol. 2020 May;37(3):490-497
pubmed: 32147881
J Am Acad Dermatol. 2019 Jan;80(1):128-138.e2
pubmed: 30003988
Am J Manag Care. 2018 Dec;24(23 Suppl):S496-S501
pubmed: 30589249
Can J Ophthalmol. 2019 Dec;54(6):e300-e302
pubmed: 31836120
CMAJ. 2005 Jan 4;172(1):69-75
pubmed: 15632408
JAMA. 2019 Jul 16;322(3):264-265
pubmed: 31219503
Am J Clin Dermatol. 2019 Feb;20(1):135-145
pubmed: 30378087
Am Fam Physician. 2018 Jun 1;97(11):729-734
pubmed: 30215934
J Am Acad Dermatol. 2016 Dec;75(6):1126-1133
pubmed: 27567033
Am J Clin Dermatol. 2019 Aug;20(4):593-604
pubmed: 31111409
Health Qual Life Outcomes. 2017 Jun 8;15(1):121
pubmed: 28595584
Pediatr Dermatol. 2019 Jan;36(1):89-99
pubmed: 30451318
Dermatol Ther (Heidelb). 2017 Mar;7(1):25-36
pubmed: 27787745
Arch Dermatol Res. 2016 Dec;308(10):743-749
pubmed: 27744497
J Patient Rep Outcomes. 2019 Sep 5;3(1):59
pubmed: 31486951